Navigation Links
PCMA Refutes Report from Oncologist Splinter Group on Medicare Part D
Date:2/1/2017

WASHINGTON, Feb. 1, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on a new report by a splinter group of oncologists attacking the use of direct and indirect remuneration (DIR) in the popular Medicare Part D program:

"Today's attack on Medicare Part D plans' tools to reduce drug costs is a thinly veiled attempt to protect certain oncologists' profits at the expense of patients and the Medicare program itself. It's no secret they prefer Medicare Part B's fee-for-service approach, which according to MedPAC, gives providers 'incentives for use of higher priced drugs when lower priced alternatives exist.'

DIR reduces premiums for Medicare Part D beneficiaries, which leads to lower costs for the federal government. Stable and affordable premiums contribute to a 90% satisfaction rate among Part D enrollees for their drug plan.

Furthermore, the paper's dubious claim that DIR in Part D contribute to higher drug prices raises an obvious question: why are drug prices so high in Medicare Part B?

In reality, Part D plans reduce costs not only by negotiating price concessions on brand and generic drugs, but also by lowering premiums, which reduces costs for all Medicare beneficiaries as well as U.S. taxpayers."

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pcma-refutes-report-from-oncologist-splinter-group-on-medicare-part-d-300400538.html


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Access Pharmaceuticals Reports First Quarter Results
3. 2013 Armada Specialty Pharmacy Summit Reports Record Attendance
4. ULURU Inc. Reports First Quarter 2013 Financial Results
5. Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
6. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
7. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
8. Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call
9. TRACE Releases 2012 Global Enforcement Report
10. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
11. LCA-Vision Reports on Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... ... 13, 2018 , ... ActivePDF , the leading global ... charitable causes through a recent partnership with California State University, Fullerton (CSUF) ... an over 300-person social gathering for adults with autism and their caregivers. ...
(Date:11/13/2018)... ... November 13, 2018 , ... Through its Microbiome ... support in study design, planning, sample collection, and analysis to a team of ... Assistant Professor of Clinical Medicine, to compare the gut microbiome in individuals with ...
(Date:11/13/2018)... ... ... Enlyte, LLC took the Healthcare Revolution Conference by storm this ... for the event’s “Innovation Awards”, which recognizes the most innovative leaders in “Transforming the ... competitor, yet they stood out as an innovator in the health and wellness industries. ...
Breaking Medicine Technology:
(Date:11/14/2018)... ... November 14, 2018 , ... Contrary to ... recycled consumer product. Lead batteries hold the honor at a whopping 99.3 percent, ... Day 2018 on November 15, the lead battery industry is proudly sharing the ...
(Date:11/13/2018)... , ... November 14, 2018 , ... ... Tool, **An FDAnews Webinar**, Nov. 28, 2018 — 1:30 p.m. – 3:00 p.m. ... a safety requirement. It’s now a powerful enforcement tool. A constantly evolving enforcement ...
(Date:11/13/2018)... ... November 13, 2018 , ... A recent public health ... naloxone, an opioid overdose reversal drug. Most states, including California, have legislation or ... prescription. , A new study by faculty at the Keck ...
(Date:11/13/2018)... ... November 13, 2018 , ... Researchers at Worcester Polytechnic ... and Acoustic MedSystems Inc., have received a five-year, $3.5 million award from the ... program, to continue development of an innovative robotic system that, operating within an ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... BTG has invested $20m in Veran Medical Technologies, Inc. and has an option ... healthcare company focused on Interventional Medicine. Their innovative medical technology helps physicians treat ...
Breaking Medicine News(10 mins):